add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Chugai Revises Corporate Advertisement for First Time in Four YearsPharmaLive.com (press release) - 21 hours ago ... to treatments in renal anemia as well as cancer, rheumatoid arthritis and hepatitis C and other disease areas where unmet medical needs are high. ... Chugai launches new corporate advertisementZenopa - Nov 25, 2009 The product met its primary endpoint in a paediatric study of systemic onset Juvenile Idiopathic Arthritis, by noticeably reducing the symptoms of the ... Updated boxed warning required for TNF blockers Food and Drug Administration's ...AAP News (subscription) - Nov 24, 2009 Enbrel (etanercept) and Humira (adalimumab) are approved for treatment of juvenile idiopathic arthritis in pediatric patients 2 years of age and older and 4 ... Immunosuppressant drug shows promise in treating anterior uveitis from ...OSN SuperSite - Nov 24, 2009 ... rash possibly caused by daclizumab, ocular treatment failure and uncontrolled systemic presentations of juvenile idiopathic arthritis, the authors said. ... ACTEMRA Improves Signs and Symptoms in Children with Systemic Onset Juvenile ...PipelineReview.com (press release) - Nov 21, 2009 sJIA is a subset of juvenile idiopathic arthritis that describes patients with intermittent fever, rash, and arthritis symptoms. Children with sJIA comprise ... Roche touts Actemra results for sJIAFierceBiotech - - Nov 20, 2009 Roche announced positive results from a late-stage trial of Actemra for systemic onset Juvenile Idiopathic Arthritis (sJIA), a disease that causes ... Roche's Actemra impresses as therapy for arthritis in childrenPharma Times - - Nov 20, 2009 ... promising late-stage data on Actemra, which shows that the drug significantly improved symptoms of systemic onset juvenile idiopathic arthritis. ... Chugai and Roche announce positive trial results for RoACTEMRAZenopa - Nov 20, 2009 The product successfully met its primary endpoint in a paediatric study of systemic onset Juvenile Idiopathic Arthritis (sJIA) of noticeably curbing ... Glance-Europe Factors-Shares set to rebound with commodsInteractive Investor - - Nov 19, 2009 For details, see: The Swiss drugmaker's rheumatoid arthritis drug, Actemra, significantly improved symptoms of systemic onset Juvenile Idiopathic Arthritis ... Swiss stocks - Factors to watch on Nov 20Interactive Investor - Nov 19, 2009 Swiss drugmaker Roche's rheumatoid arthritis drug, Actemra, significantly improved symptoms of systemic onset Juvenile Idiopathic Arthritis (sJIA), ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
